#United States #San Diego #Singular Genomics #G4X™ #Spatial Research

Singular Genomics Launches G4X™ Spatial Research Challenge

Singular Genomics, a leading player in the field of life science technology, has recently announced an innovative initiative called the G4X™ Spatial Research Challenge. This program is designed to award funding for a spatial multiomics study involving up to 1,000 samples, paving the way for groundbreaking research in oncology and translational science.

The G4X platform is uniquely positioned to transform the landscape of spatial biology. Traditional research designs in this area often face challenges such as throughput limitations, complex workflows, high costs, and the practical constraints of sample scale. With the introduction of this challenge, Singular Genomics aims to remove these barriers, empowering researchers to conduct comprehensive multimodal spatial studies using this large cohort.

A Flagship Award for Enhanced Research

The standout component of this initiative is the flagship award, which will finance a service-based study that utilizes G4X on up to 1,000 samples. This is a significant leap forward for the research community. Each selected project will be allowed to integrate up to 1,000-plex RNA, 16-plex protein, and fHE in individual samples. This will enable a rich, integrated multimodal analysis that can yield insights at a subcellular level across extensive cohorts.

Josh Stahl, CEO of Singular Genomics, underscored the profound possibilities this initiative opens up: _"Spatial biology has delivered extraordinary insight, but too often at a scale that limited its broader translational impact. With the G4X Spatial Research Challenge, we want to enable studies large enough to generate more robust biology, stronger validation, and deeper clinical relevance.”_

Additional Opportunities for Researchers

Beyond the primary award, Singular Genomics will be accepting submissions for a second category focusing on 3D reconstruction from serial FFPE sections. This category is designed to support innovative projects involving up to eight 40 µm reconstructions or four 80 µm reconstructions, incorporating 16-plex protein and up to 1,000-plex RNA along with fHE utilizing the G4X platform. This targeted approach aims to further enrich the scope of research possibilities.

The challenge is open to all researchers engaged in high-impact studies in various fields, including oncology, biomarker discovery, therapy response, and studying disease heterogeneity. This initiative will help propel translational insights, ultimately contributing to advancements in precision medicine.

G4X: A Game-Changer in Spatial Analysis

The G4X™ platform, recently launched in the United States, enables high-throughput spatial analysis from FFPE tissue. By facilitating integrated spatial readouts of RNA, protein, and tissue morphology in a single run, G4X delivers subcellular resolution and multimodal insights. This technology aims to expand the capabilities for translational and clinical research applications, marking a significant step forward in high-throughput solutions for spatial pathology.

Singular Genomics is committed to making high-throughput spatial studies practical and accessible, aligning with its mission to advance precision medicine through innovative technology.

For further information regarding eligibility, submission requirements, review criteria, and timelines, interested parties should visit singulargenomics.com/grant-challenge. Proposals must be submitted by May 22nd.

In conclusion, Singular Genomics’ new G4X™ Spatial Research Challenge represents a remarkable opportunity for researchers to explore the full potential of spatial biology at an unprecedented scale. With enhanced access to high-throughput analysis, the challenge aims to catalyze significant advancements in clinical research and patient care.